
Conference Coverage
Latest Content

Potential Survival Edge in Multiple Myeloma From CV Meds

Health Equity & Access Weekly Roundup: February 27, 2026

Guideline Updates Refine Management for Very High-Risk Squamous Cell Skin Cancer

Allergic Contact Dermatitis Linked to Emotional and Functional Decline

Revised Childhood Immunization Schedule Lacks Transparency: Noel T. Brewer, PhD

Shorts










Podcasts
Center on Health Equity & Access
Continuing Medical Education
All News

A Mississippi hospital partners with Eko Health to introduce AI-assisted cardiac detection in underserved rural communities.

High area level housing cost burden is associated with increased cardiovascular hospitalizations and emergency department use among Medicaid beneficiaries.

340B covered entities are expanding contracts with retail pharmacies that are increasingly located in counties with high rates of Medicare and Medicaid insurance coverage.

Enfortumab vedotin plus pembrolizumab boosts survival and pCR in muscle-invasive bladder cancer, according to EV-304 trial data.

Measles outbreaks are emerging across the country, continuing the increasing trend in cases that began in 2025.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Azathioprine use in organ transplant recipients increases the risk of squamous cell, but not basal cell, carcinoma.

Experts examine evolving long COVID definitions, risk factors, diagnosis challenges, vaccine impact, and workforce effects.

ACOs entering MSSP with higher spending were consistently more likely to earn bonuses—a gap that persisted after a 2017 benchmarking policy change.

This approval was based on data from the Beamion LUNG-1 trial.



































